Vivimed Labs CFO Phaninder Nath P S resigns citing health reasons

Cfo ResignedManagement Changes View source PDF Explain this filing

VIVIMEDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.9%Reaction day

₹7.58

prior close

₹7.21

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%-4.1% vs market

On the reaction day the stock moved 4.1 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-4.9-0.8-4.1

Next day

-0.1+1.8-1.9

-5.7+2.8-8.5

-10.3+2.3-12.6

-5.8+1.8-7.6

-3.0+0.3-3.3

-3.8+0.5-4.3

15d

-0.7-2.5+1.9

-5.9-6.3+0.4

-19.9-8.0-12.0

-10.9+8.3-19.2

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vivimed Labs disclosed that its Chief Financial Officer, Mr. Phaninder Nath P S, has resigned effective close of business hours on February 6, 2026, citing personal health issues requiring treatment. He was classified as a Key Managerial Personnel and Senior Management Personnel under the Companies Act and SEBI Listing Regulations. The company has not yet announced a replacement in this filing.

Likely market impact

CFO exit creates a finance leadership gap. Watch for a successor announcement; health-related departure suggests it is not acrimonious, but uncertainty may weigh briefly on sentiment.